Medlab Clinical Ltd (ASX:MDC) managing director & CEO Sean Hall visits Proactive's Sydney studio following participation at the Australian Pharmacy Professional Conference & Trade Exhibition (APP2019).
Hall updates on the progress of clinical trials for NRGBiotic™, a nutraceutical already available in pharmacies.
He also discusses a recent heads of agreement (HoA) reached with Canadian pharmaceutical company Pharmascience Inc. for the further development and global distribution of NanaBis™, which is also progressing through clinical trials.
Original Article: Medlab Clinical chief updates on progress with NanaBis and NRG Biotic